BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3024008)

  • 1. A chimaeric receptor allows insulin to stimulate tyrosine kinase activity of epidermal growth factor receptor.
    Riedel H; Dull TJ; Schlessinger J; Ullrich A
    Nature; 1986 Nov 6-12; 324(6092):68-70. PubMed ID: 3024008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation and regulation of the insulin receptor kinase.
    Ballotti R; Baron V; Gautier N; Hainaut P; Scimeca JC; Dolais-Kitabgi J; Lammers R; Schlessinger J; Ullrich A; Van Obberghen E
    Diabete Metab; 1992; 18(1 Pt 2):98-103. PubMed ID: 1314199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential heat stress stability of epidermal growth factor receptor and erbB-2 receptor tyrosine kinase activities.
    Liu SM; Carpenter G
    J Cell Physiol; 1993 Nov; 157(2):237-42. PubMed ID: 7901224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor.
    Chen WS; Lazar CS; Poenie M; Tsien RY; Gill GN; Rosenfeld MG
    Nature; 1987 Aug 27-Sep 2; 328(6133):820-3. PubMed ID: 3498122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of tyrosine kinases by alpha1A-adrenergic and growth factor receptors in transfected PC12 cells.
    Zhong H; Minneman KP
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):889-94. PubMed ID: 10585878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
    Ahmad F; Goldstein BJ
    J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth factor receptors: structure, mechanism, and drug discovery.
    McInnes C; Sykes BD
    Biopolymers; 1997; 43(5):339-66. PubMed ID: 9566117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
    Putz T; Culig Z; Eder IE; Nessler-Menardi C; Bartsch G; Grunicke H; Uberall F; Klocker H
    Cancer Res; 1999 Jan; 59(1):227-33. PubMed ID: 9892211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of mitogenic pathways through kinase-impaired mutants of the epidermal growth factor receptor.
    Ewald JA; Coker KJ; Price JO; Staros JV; Guyer CA
    Exp Cell Res; 2001 Aug; 268(2):262-73. PubMed ID: 11478852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal transduction through the IL-4 and insulin receptor families.
    Wang LM; Keegan A; Frankel M; Paul WE; Pierce JH
    Stem Cells; 1995 Jul; 13(4):360-8. PubMed ID: 7549895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfer of functional EGF receptors to an IL3-dependent cell line.
    Collins MK; Downward J; Miyajima A; Maruyama K; Arai K; Mulligan RC
    J Cell Physiol; 1988 Nov; 137(2):293-8. PubMed ID: 3263970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
    Comoglio PM
    EXS; 1993; 65():131-65. PubMed ID: 8380735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptors for insulin and epidermal growth factor: interaction with organomercurial agarose.
    Aglio LS; Maturo JM; Hollenberg MD
    J Cell Biochem; 1985; 28(2):143-57. PubMed ID: 3001106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemical structure, active sites and receptor binding of insulin molecule and its signal transduction].
    Ishida H; Nagamatsu S
    Nihon Rinsho; 2001 Nov; 59(11):2109-16. PubMed ID: 11712394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Insulin receptors: structure and physiology].
    Canivet B; Jullien D; Sadoul JL; Freychet P
    Rev Prat; 1992 Jun; 42(11):1400-5. PubMed ID: 1529256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar but different: ligand-induced activation of the insulin and epidermal growth factor receptor families.
    Ward CW; Lawrence MC
    Curr Opin Struct Biol; 2012 Jun; 22(3):360-6. PubMed ID: 22521506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-translational acquisition of ligand binding- and tyrosine kinase-domain function by the epidermal growth factor and insulin receptors.
    Lane MD; Slieker LJ; Olson TS; Martensen TM
    J Recept Res; 1987; 7(1-4):321-54. PubMed ID: 3305909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermolecular transphosphorylation between insulin receptors and EGF-insulin receptor chimerae.
    Ballotti R; Lammers R; Scimeca JC; Dull T; Schlessinger J; Ullrich A; Van Obberghen E
    EMBO J; 1989 Nov; 8(11):3303-9. PubMed ID: 2583100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulphydryl agents modulate insulin- and epidermal growth factor (EGF)-receptor kinase via reaction with intracellular receptor domains: differential effects on basal versus activated receptors.
    Clark S; Konstantopoulos N
    Biochem J; 1993 May; 292 ( Pt 1)(Pt 1):217-23. PubMed ID: 8389126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.